Title:
ＢＴＫ阻害剤化合物
Document Type and Number:
Japanese Patent JP6920553
Kind Code:
B2
Abstract:
The invention provides BTK Inhibitor compounds of the formulapharmaceutically acceptable salts, pharmaceutical compositions thereof, and methods of using these compounds, salts, or compositions to treat autoimmune diseases such as Rheumatoid Arthritis.
Inventors:
Henry, Kenneth James, Jr.
Kilbic, Albert
Kuklish, Steven, Lee
Partridge, Catherine, Marie
Quimby, Stephen, James
Kilbic, Albert
Kuklish, Steven, Lee
Partridge, Catherine, Marie
Quimby, Stephen, James
Application Number:
JP2020523393A
Publication Date:
August 18, 2021
Filing Date:
October 30, 2018
Export Citation:
Assignee:
Eli Lilly and Company
International Classes:
C07D401/14; A61K31/506; A61P17/00; A61P19/02; A61P25/00; A61P29/00; A61P37/06
Foreign References:
| US20140162983 | ||||
| WO2012170976A1 | ||||
| WO2014093230A1 | ||||
| US20150152068 |
Attorney, Agent or Firm:
Hiroshi Kobayashi
Eiji Katayama
Norio Omori
Inori Toshihiro
Yasuhito Suzuki
Eiji Katayama
Norio Omori
Inori Toshihiro
Yasuhito Suzuki